+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hematologic Malignancy Drug"

Hematologic Malignancies Market Report by Type, Therapy, End User, and Region 2026-2034 - Product Thumbnail Image

Hematologic Malignancies Market Report by Type, Therapy, End User, and Region 2026-2034

  • Report
  • May 2026
  • 148 Pages
  • Global
From
Cancer Immunotherapy Drug Discovery Outsourcing Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Immunotherapy Drug Discovery Outsourcing Market - Global Forecast 2026-2032

  • Report
  • July 2026
  • 196 Pages
  • Global
From
Cancer Immunotherapy Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Immunotherapy Drugs Market - Global Forecast 2026-2032

  • Report
  • July 2026
  • 194 Pages
  • Global
From
Cancer Supportive Care Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Supportive Care Drugs Market - Global Forecast 2026-2032

  • Report
  • July 2026
  • 181 Pages
  • Global
From
Cancer Biological Therapy Market by Therapy Type, Administration Route, Application, End User, Distribution Channel - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Biological Therapy Market by Therapy Type, Administration Route, Application, End User, Distribution Channel - Global Forecast 2026-2032

  • Report
  • June 2026
  • 184 Pages
  • Global
From
Cancer Immunotherapy Market by Therapy Type, Mechanism of Action, Line of Therapy, Route of Administration, Indication, End User - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Immunotherapy Market by Therapy Type, Mechanism of Action, Line of Therapy, Route of Administration, Indication, End User - Global Forecast 2026-2032

  • Report
  • June 2026
  • 180 Pages
  • Global
From
Filgrastim & Biosimilars Market - Global Forecast 2025-2030 - Product Thumbnail Image

Filgrastim & Biosimilars Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 190 Pages
  • Global
From
Hematologic Malignancies Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Disease Condition (Leukemia, Lymphoma, Myeloma), Therapy, End User - Product Thumbnail Image

Hematologic Malignancies Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Disease Condition (Leukemia, Lymphoma, Myeloma), Therapy, End User

  • Report
  • July 2026
  • 160 Pages
  • Global
From
Hematologic Malignancies Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Hematologic Malignancies Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • October 2025
  • 150 Pages
  • Global
From
Hematologic Malignancies Market Size, Share & Trends Analysis Report By Disease (Leukemia, Lymphoma), By Therapy (Chemotherapy, Immunotherapy), By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Thumbnail Image

Hematologic Malignancies Market Size, Share & Trends Analysis Report By Disease (Leukemia, Lymphoma), By Therapy (Chemotherapy, Immunotherapy), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • August 2024
  • 120 Pages
  • Global
From
Hematologic Malignancies Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Hematologic Malignancies Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 111 Pages
  • Global
From
  • 11 Results (Page 1 of 1)
Loading Indicator

The Hematologic Malignancy Drug market is a subset of the Oncology Drugs market, which focuses on the treatment of blood cancers such as leukemia, lymphoma, and myeloma. These drugs are used to treat both acute and chronic forms of these diseases, and can be administered orally, intravenously, or subcutaneously. Common drugs used in this market include chemotherapy, targeted therapy, immunotherapy, and stem cell transplantation. The Hematologic Malignancy Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in this market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more